Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 10:20 PM
Ignite Modification Date: 2025-12-26 @ 10:20 PM
NCT ID: NCT04959812
Description: None
Frequency Threshold: 0
Time Frame: Adverse data was collected over the 6 hours of the study.
Study: NCT04959812
Study Brief: Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Sufentanil
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Sufentanil Sufentanil (30 microgram tablet) will be administered via a sublingual pill Sufentanil: Subjects will receive Sufentanil while the effects of this drug on tolerance to a hemorrhagic insult will be assessed. 0 None 0 29 0 29 View
Placebo Placebo will be administered via a sublingual pill Placebo: Subjects will receive a placebo pill while the effects of this placebo on tolerance to a hemorrhagic insult will be assessed. 0 None 0 29 0 29 View
Serious Events(If Any):
Other Events(If Any):